Saliva is Comparable to Nasopharyngeal Swabs for Molecular Detection of SARS-CoV-2

被引:26
作者
Callahan, Cody [1 ,2 ]
Ditelberg, Sarah [2 ]
Dutta, Sanjucta [2 ]
Littlehale, Nancy [4 ]
Cheng, Annie [2 ]
Kupczewski, Kristin [2 ]
McVay, Danielle [2 ]
Riedel, Stefan [2 ,4 ,5 ]
Kirby, James E. [2 ,4 ,5 ]
Arnaout, Ramy [2 ,3 ,4 ,5 ]
机构
[1] Beth Israel Deaconess Med Ctr, Dept Radiol, Boston, MA 02215 USA
[2] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA
[3] Beth Israel Deaconess Med Ctr, Div Clin Informat, Dept Med, Boston, MA 02215 USA
[4] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[5] Harvard Med Sch, Boston, MA 02115 USA
关键词
SARS-CoV-2; COVID-19; saliva; NP swab; limit of detection;
D O I
10.1128/Spectrum.00162-21
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The continued need for molecular testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the potential for self-collected saliva as an alternative to nasopharyngeal (NP) swabs for sample acquisition led us to compare saliva to NP swabs in an outpatient setting without restrictions to avoid food, drink, smoking, or tooth-brushing. A total of 385 pairs of NP and saliva specimens were obtained, the majority from individuals presenting for initial evaluation, and were tested on two high-sensitivity reverse transcriptase PCR (RT-PCR) platforms, the Abbott m2000 and Abbott Alinity m (both with limits of detection OD] of 100 copies of viral RNA/ml). Concordance between saliva and NP swabs was excellent overall (Cohen's kappa = 0.93) for both initial and follow-up testing, for both platforms, and for specimens treated with guanidinium transport medium as preservative as well as for untreated saliva (kappa = 0.88 to 0.95). Viral loads were on average 16x higher in NP specimens than saliva specimens, suggesting that only the relatively small fraction of outpatients (similar to 8% in this study) who present with very low viral loads (<1,600 copies/ml from NP swabs) would be missed by testing saliva instead of NP swabs when using sensitive testing platforms. Special attention was necessary to ensure leak-resistant specimen collection and transport. The advantages of self-collection of saliva, without behavioral restrictions, will likely outweigh a minor potential decrease in clinical sensitivity in individuals less likely to pose an infectious risk to others for many real-world scenarios, especially for initial testing. IMPORTANCE In general, the most accurate COVID-19 testing is hands-on and uncomfortable, requiring trained staff and a "brain-tickling" nasopharyngeal swab. Saliva would be much easier on both fronts, since patients could collect it themselves, and it is after all just spit. However, despite much interest, it remains unclear how well saliva performs in real-world settings when just using it in place of an NP swab without elaborate or cumbersome restrictions about not eating/drinking before testing, etc. Also, almost all studies of COVID-19 testing, whether of NP swabs, saliva, or otherwise, have been restricted to reporting results in the abstruse units of "C-T values," which only mean something in the context of a specific assay and testing platform. Here, we compared saliva versus NP swabs in a real-world setting without restriction and report all results in natural units-the amount of virus being shed-showing that saliva is essentially just as good as NP swabs.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 23 条
[1]   The Limit of Detection Matters: The Case for Benchmarking Severe Acute Respiratory Syndrome Coronavirus 2 Testing [J].
Arnaout, Ramy ;
Lee, Rose A. ;
Lee, Ghee Rye ;
Callahan, Cody ;
Cheng, Annie ;
Yen, Christina F. ;
Smith, Kenneth P. ;
Arora, Rohit ;
Kirby, James E. .
CLINICAL INFECTIOUS DISEASES, 2021, 73 (09) :E3042-E3046
[2]   Saliva is a reliable tool to detect SARS-CoV-2 [J].
Azzi, Lorenzo ;
Carcano, Giulio ;
Gianfagna, Francesco ;
Grossi, Paolo ;
Dalla Gasperina, Daniela ;
Genoni, Angelo ;
Fasano, Mauro ;
Sessa, Fausto ;
Tettamanti, Lucia ;
Carinci, Francesco ;
Maurino, Vittorio ;
Rossi, Agostino ;
Tagliabue, Angelo ;
Baj, Andreina .
JOURNAL OF INFECTION, 2020, 81 (01) :E45-E50
[3]   CONTROLLING THE FALSE DISCOVERY RATE - A PRACTICAL AND POWERFUL APPROACH TO MULTIPLE TESTING [J].
BENJAMINI, Y ;
HOCHBERG, Y .
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY, 1995, 57 (01) :289-300
[4]  
Berenger BM, 2020, MEDRXIV, DOI [10.1101/2020.05.05.20084889, DOI 10.1101/2020.05.05.20084889]
[5]  
Callahan Cody, 2020, medRxiv, DOI 10.1101/2020.06.12.20128736
[6]   Open Development and Clinical Validation of Multiple 3D-Printed Nasopharyngeal Collection Swabs: Rapid Resolution of a Critical COVID-19 Testing Bottleneck [J].
Callahan, Cody J. ;
Lee, Rose ;
Zulauf, Katelyn E. ;
Tamburello, Lauren ;
Smith, Kenneth P. ;
Previtera, Joe ;
Cheng, Annie ;
Green, Alex ;
Azim, Ahmed Abdul ;
Yano, Amanda ;
Doraiswami, Nancy ;
Kirby, James E. ;
Arnaout, Ramy A. .
JOURNAL OF CLINICAL MICROBIOLOGY, 2020, 58 (08)
[7]   Evaluation of Specimen Types and Saliva Stabilization Solutions for SARS-CoV-2 Testing [J].
Griesemer, Sara B. ;
Van Slyke, Greta ;
Ehrbar, Dylan ;
Strle, Klemen ;
Yildirim, Tugba ;
Centurioni, Dominick A. ;
Walsh, Anne C. ;
Chang, Andrew K. ;
Waxman, Michael J. ;
St George, Kirsten .
JOURNAL OF CLINICAL MICROBIOLOGY, 2021, 59 (05)
[8]  
Kojima N, 2020, CLIN INFECT DIS, V73, P3106
[9]  
LeBlanc JJ, 2020, J CLIN VIROL, V128
[10]   Performance of Saliva, Oropharyngeal Swabs, and Nasal Swabs for SARS-CoV-2 Molecular Detection: a Systematic Review and Meta-analysis [J].
Lee, Rose A. ;
Herigon, Joshua C. ;
Benedetti, Andrea ;
Pollock, Nira R. ;
Denkinger, Claudia M. .
JOURNAL OF CLINICAL MICROBIOLOGY, 2021, 59 (05)